Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-18-008997.pdf
0001179110-18-008997.rtf
0001179110-18-008997.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-18-008996.pdf
0001179110-18-008996.rtf
0001179110-18-008996.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-18-009001.pdf
0001179110-18-009001.rtf
0001179110-18-009001.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-18-009000.pdf
0001179110-18-009000.rtf
0001179110-18-009000.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-18-008999.pdf
0001179110-18-008999.rtf
0001179110-18-008999.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-18-008998.pdf
0001179110-18-008998.rtf
0001179110-18-008998.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-18-009003.pdf
0001179110-18-009003.rtf
0001179110-18-009003.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-18-009004.pdf
0001179110-18-009004.rtf
0001179110-18-009004.xls
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-18-005408.pdf
0001558370-18-005408.rtf
0001558370-18-005408.xls
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-18-005297.pdf
0001558370-18-005297.rtf
0001558370-18-005297.xls